Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 3 complete abstracts (733 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Design, Research; Designs, Research; Research Designs; Data Reporting; Reporting, Data; Experimental Design; Design, Experimental; Designs, Experimental.
Where it fits in the MeSH classification
- Broader topics
- Methods; Research
- Narrower topics
- Control Groups; Double-Blind Method; Early Termination of Clinical Trials; Meta-Analysis as Topic; Patient Selection; Random Allocation; Sample Size
- See also
- Clinical Trials Data Monitoring Committees
Research landscape
PubMed indexes 528,235 records tagged with the MeSH heading “Research Design” (counts retrieved 2026-10-29). 85,367 of them (16.2%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 173,006 records.
Reviews account for 58,708 records (11.1%) and meta-analyses for 5,562. Randomized controlled trials number 177,251 (33.6%) as a share of all records on the topic. Randomized trials make up a comparatively large share of this literature, which means many treatment questions have been tested directly.
Show the data
| Period | Records |
|---|---|
| through 1999 | 132,085 |
| 2000-2009 | 137,777 |
| 2010-2019 | 173,006 |
| 2020 onward | 85,367 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 58,708 | 11.1% |
| Meta-analyses | 5,562 | 1.1% |
| Randomized controlled trials | 177,251 | 33.6% |
Method: PubMed query "Research Design"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in clinical research
Research methods determine how much a result can be trusted. Randomized trials guard against confounding, systematic reviews and meta-analyses combine many studies, and observational designs are valuable but can show only association. Reporting standards, trial registration and pre-specified outcomes reduce bias. When reading about a method, ask what problem it is designed to solve and which problems it does not solve.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis | 2026 | Meta-analysis Design not recorded in structured metadata | 5 | cc by PMID 42156120 · DOI · PMC13184834 |
| Value and Credibility of Meta-Analysis: Tutorial on Enhancing Methodological Rigor and AI-Powered Efficiency | 2026 | Research article Design not recorded in structured metadata | 3 | cc by PMID 42390911 · DOI · PMC13376850 |
| Improving the design of observational studies in orthopaedics: a practical guide to target trial emulation | 2026 | Review article Design not recorded in structured metadata | 2 | cc by PMID 42287372 · DOI · PMC13524998 |
Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis [1]
Abstract reading summary — source excerpts
- Opening excerpt
- ObjectivesTo assess the concordance of results between paired target trial emulations and their benchmarking randomised controlled trials and to explore determinants of emulation success.
- Closing excerpt
- Systematic review registrationPROSPERO CRD42024619811.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (320 words)
ObjectivesTo assess the concordance of results between paired target trial emulations and their benchmarking randomised controlled trials and to explore determinants of emulation success.DesignSystematic review and meta-analysis.Data sourcesMedline, EMBASE, Scopus, PsycINFO, and Web of Science (2010 to 2025).Study selectionObservational studies that explicitly aimed to emulate target randomised controlled trials of a health intervention were included.Data extractionData were extracted on study domain, target population, intervention, comparator, and main outcomes for each emulation and corresponding randomised controlled trial.Main outcome measuresFor 21 predefined emulation design features, concordance was assessed using Pearson correlation coefficients, standardised difference agreement, and ratio of ratios, with subgroup and regression analyses of study characteristics and concordance.ResultsAmong 107 target trial emulation-randomised controlled trial pairs, the Pearson correlation coefficient was 0.59 (95% confidence interval (CI) 0.45 to 0.70), standardised difference agreement was 79% (85/107), and summary ratio of ratios was 0.96 (95% CI 0.92 to 1.01; I2=36%). In 63 pairs with closer emulation of trial design, a higher level of agreement was observed, with a Pearson correlation coefficient of 0.83 (0.73 to 0.89) and standardised difference agreement of 87% (55/63). In subgroup analysis, trial emulations tended to systematically underestimate treatment effects from randomised controlled trials for specific outcomes related to venous thromboembolism and major adverse cardiovascular events, while overestimating those for respiratory outcomes, with pooled ratio of ratios of 0.76 (0.58 to 1.00; I2=40%), 0.91 (0.86 to 0.96; I2=32%), and 1.20 (1.03 to 1.40; I2=40%), respectively. Moreover, emulations based on claims data tended to underestimate the treatment effects (ratio of ratios 0.90, 0.82 to 0.99; I2=38%). In univariate regression analyses, poorer target trial emulation-randomised controlled trial concordance was associated with emulation designs with imbalanced baseline population characteristics, treatment started in hospital, and lower outcome emulation quality.ConclusionsCurrent target trial emulations achieve moderate concordance when replicating their corresponding randomised controlled trials. Concordance could be improved by better emulation design, including better baseline and outcome emulation and leveraging multisource linked databases.Systematic review registrationPROSPERO CRD42024619811.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42156120 · DOI · PMC13184834
Value and Credibility of Meta-Analysis: Tutorial on Enhancing Methodological Rigor and AI-Powered Efficiency [2]
Abstract reading summary — source excerpts
- Opening excerpt
- The value of a meta-analysis is based on its methodological and statistical rigor, yet many published systematic reviews and meta-analyses contain statistical shortcomings that limit their utility for clinical practice and public health.
- Closing excerpt
- This guide is intended to help authors enhance the rigor of their work and use new technologies to ensure their findings are both trustworthy and timely.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (170 words)
The value of a meta-analysis is based on its methodological and statistical rigor, yet many published systematic reviews and meta-analyses contain statistical shortcomings that limit their utility for clinical practice and public health. This can make it challenging to aggregate data for treatment choices for patients as well as limit the extent to which policymakers can promote social change and improve public health. This challenge is compounded by the traditionally slow and resource-intensive nature of systematic reviews, which delays the translation of vital evidence. In this tutorial, we address both challenges. We first provide a primer on essential statistical techniques to help authors produce more robust and reliable meta-analyses. We then briefly discuss the growing role of artificial intelligence (AI) in automating tasks in systematic literature reviews and meta-analyses. Ethical use and disclosure of AI in supporting these essential tasks are also important considerations. This guide is intended to help authors enhance the rigor of their work and use new technologies to ensure their findings are both trustworthy and timely.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42390911 · DOI · PMC13376850
Improving the design of observational studies in orthopaedics: a practical guide to target trial emulation [3]
Abstract reading summary — source excerpts
- Opening excerpt
- PurposeTo explain how target trial emulation can help orthopaedic researchers design observational studies that are more clinically interpretable and less vulnerable to avoidable design bias.
- Closing excerpt
- Its application may help orthopaedic researchers produce studies that are more transparent, clinically interpretable, and better aligned with decision-making in practice.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (243 words)
PurposeTo explain how target trial emulation can help orthopaedic researchers design observational studies that are more clinically interpretable and less vulnerable to avoidable design bias.MethodsWe provide a methodological overview of target trial emulation for orthopaedic research, using the comparison of postoperative outcomes after total hip arthroplasty versus bipolar hemiarthroplasty for hip fracture as an illustrative example. The review focused on translating a causal question into a target trial protocol, how conventional observational designs can introduce bias, and how routinely collected data can be used to emulate a target trial when key design conditions are met.ResultsTarget trial emulation begins by specifying the clinical question, hypothetical trial, and assumptions required for causal interpretation. This explicit specification is particularly relevant to orthopaedic observational research, wherein treatment decisions are often influenced by prognosis, functional status, surgeon judgment, and institutional context. Conventional observational analyses may be difficult to interpret when the eligibility criteria include patients for whom one treatment is not realistic, treatment labels combine important procedural variations, treatment assignment and follow-up are not aligned at time zero, or post-baseline information is used to modify follow-up or exclude patients. This framework can emphasise these problems before analysis, although it cannot overcome residual confounding, poor measurement, informative loss to follow-up, or other data limitations.ConclusionsTarget trial emulation can guide observational studies' design around treatment decisions encountered in routine practice. Its application may help orthopaedic researchers produce studies that are more transparent, clinically interpretable, and better aligned with decision-making in practice.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42287372 · DOI · PMC13524998
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Meta-analysis of prevalence [4]
- Research article Plea for routinely presenting prediction intervals in meta-analysis [5]
- Research article Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation [6]
- Research article Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis [7]
- Research article Spanking and child outcomes: Old controversies and new meta-analyses [8]
- Research article Retention strategies in longitudinal cohort studies: a systematic review and meta-analysis [9]
References
- Wang C, Tang D, von Dadelszen P, Ju C, Liu L, Wang Y, et al.. Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis. . 2026. PMID 42156120 · DOI · PMC13184834
- Brini S, Leung TI. Value and Credibility of Meta-Analysis: Tutorial on Enhancing Methodological Rigor and AI-Powered Efficiency. . 2026. PMID 42390911 · DOI · PMC13376850
- Hatano M, Kimura Y, Yasunaga H, Tanaka S. Improving the design of observational studies in orthopaedics: a practical guide to target trial emulation. . 2026. PMID 42287372 · DOI · PMC13524998
- Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013. PMID 23963506 · DOI
- IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016. PMID 27406637 · DOI · PMC4947751
- Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation. J Natl Cancer Inst. 2019. PMID 30856272 · DOI · PMC6410951
- Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, et al.. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018. PMID 30487232 · DOI · PMC6259046
- Gershoff ET, Grogan-Kaylor A. Spanking and child outcomes: Old controversies and new meta-analyses. J Fam Psychol. 2016. PMID 27055181 · DOI · PMC7992110
- Teague S, Youssef GJ, Macdonald JA, Sciberras E, Shatte A, Fuller-Tyszkiewicz M, et al.. Retention strategies in longitudinal cohort studies: a systematic review and meta-analysis. BMC Med Res Methodol. 2018. PMID 30477443 · DOI · PMC6258319
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.